Kuros Biosciences Announces Start of Randomized Controlled Trial of MagnetOs in Spinal Fusion
June 12, 2018 01:00 ET
|
Kuros Biosciences
Study Should Further Enhance Competitive Positioning of MagnetOs SCHLIEREN (ZURICH), Switzerland, June 12, 2018 (GLOBE NEWSWIRE) -- Kuros Biosciences (SIX:KURN) announced today that the University...
Kuros Biosciences to Propose Appointment of New Board Members at AGM
May 31, 2018 11:30 ET
|
Kuros Biosciences
SCHLIEREN (ZURICH), Switzerland, May 31, 2018 (GLOBE NEWSWIRE) -- Kuros Biosciences (SIX:KURN) will propose the appointment of CEO Joost de Bruijn, as well as three new independent non-executive...
Kuros Biosciences Announces Start of Investigator-Led Study of MagnetOs Granules for Maxillary Sinus Floor Elevation
May 29, 2018 11:30 ET
|
Kuros Biosciences
SCHLIEREN (ZURICH), Switzerland, May 29, 2018 (GLOBE NEWSWIRE) -- Kuros Biosciences (SIX:KURN) announced today the start of an investigator-led study at University Medical Center (UMC) Utrecht,...
Kuros Biosciences Receives European Clearance for MagnetOs Putty and Prepares for Commercial Roll-Out in the U.S. and Europe
May 02, 2018 01:00 ET
|
Kuros Biosciences
SCHLIEREN (ZURICH), Switzerland, May 02, 2018 (GLOBE NEWSWIRE) -- Kuros Biosciences (SIX:KURN) announced today that it has received the CE Mark for MagnetOs Putty indicated for use as an...
Kuros Biosciences Reports Full-Year 2017 Results
April 30, 2018 01:00 ET
|
Kuros Biosciences
Financial highlights CHF 17.0 million cash at year-endCHF 16.9 million equity raise in June 2017Standby equity facility established in November 2017 to increase financial flexibility Operational...